Federal Circuit Finds Inequitable Conduct Based on a Pattern of Misdirected Statements to the USPTO.
Mondaq Business Briefing › Nbr. 2005, January 2005
Linked as:
Summary
Purdue Pharma L.P. v. Endo Pharmaceuticals Inc.
See the full content of this document
Extract
Federal Circuit Finds Inequitable Conduct Based on a Pattern of Misdirected Statements to the USPTO.
Applying Rule 56 as amended by the U.S. Patent and Trademark Office (USPTO) in 1992, the U.S. Court of Appeals for the Federal Circuit upheld the district court's determination of inequitable conduct where the patent...
See the full content of this document
Sponsored links
